生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | The ataxia telangiectasia mutated (ATM) and ATM-related (ATR) kinases facilitate the resistance of cancer cells to genotoxic agents. CGK733 is a thiourea-containing compound that inhibits both ATM and ATR with IC50 values of ~200nM. Treatment of MCF-7 breast cancer cells with 10μM CGK733 reduced the expression of cyclin D1 within 2h of exposure. CGK733 at 5-20μM induced a loss of cyclin D1 protein in T47D cells. In MCF-7 cells, treatment with CGK733 at 10μM for 24h reduced the expression of both phosphorylated and total retinoblastoma tumor suppressor protein. CGK733 at a dosage of 10μM inhibited the proliferation of MCF-7, T47D, HCT116, BALB/c3T3, MDA-MB436, and LnCap cancer cells.[3] In mice inoculated with D54-ATMR cells, treatment with CGK733 (25mg/kg) for 1, 4, and 8h induced an increase in ATM reporter activity with 2.4-fold, 3.1-fold, and 1.3-fold changes, respectively, over the control group.[4] | ||
作用机制 | CGK733 is a small-molecule inhibitor of both ATM and ATR.[3] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.80mL 0.36mL 0.18mL |
9.00mL 1.80mL 0.90mL |
17.99mL 3.60mL 1.80mL |
参考文献 |
---|